71
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of alcohol septal ablation in patients over 65 years old with obstructive hypertrophic cardiomyopathy

, , , , , & show all
Pages 467-473 | Published online: 03 Mar 2017

References

  • OlivottoIOmmenSRMaronMSCecchiFMaronBJSurgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?J Am Coll Cardiol200750983183417719467
  • SorajjaPOmmenSRHolmesDRJrSurvival after alcohol septal ablation for obstructive hypertrophic cardiomyopathyCirculation2012126202374238023076968
  • VeselkaJKrejciJTomasovPZemanekDLong-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general populationEur Heart J201435302040204524464834
  • VeselkaJKrejciJTomasovPSurvival of patients ≤50 years of age after alcohol septal ablation for hypertrophic obstructive cardiomyopathyCan J Cardiol201430663463824882534
  • SteggerdaRCDammanKBaltJCLiebregtsMten BergJMvan den BergMPPeriprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy: a single-center experienceJACC Cardiovasc Interv20147111227123425326737
  • VeselkaJDuchonovaRPalenickovaJAge-related hemodynamic and morphologic differences in patients undergoing alcohol septal ablation for hypertrophic obstructive cardiomyopathyCirc J200670788088416799242
  • MaronBJHypertrophic cardiomyopathy: a systematic reviewJAMA2002287101308132011886323
  • MaronBJMcKennaWJDanielsonGKAmerican college of cardiology/European society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American college of cardiology foundation task force on clinical expert consensus documents and the European society of cardiology committee for practice guidelinesEur Heart J200324211965199114585256
  • GershBJMaronBJBonowRO2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesCirculation2011124242761279622068435
  • FayWPTaliercioCPIlstrupDMTajikAJGershBJNatural history of hypertrophic cardiomyopathy in the elderlyJ Am Coll Cardiol19901648218262212364
  • LeverHMKaramRFCurriePJHealyBPHypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shapeCirculation19897935805892917389
  • LeonardiRATownsendJCPatelCAAlcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patientsCatheter Cardiovasc Interv201382583884522936613
  • GietzenFHLeunerCJObergasselLStrunk-MuellerCKuhnHTranscoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patientsHeart200490663864415145866
  • FaberLWelgeDFassbenderDSchmidtHKHorstkotteDSeggewissHOne-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical responseClin Res Cardiol2007961286487317891518
  • VeselkaJJensenMKLiebregtsMLong-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registryEur Heart J201637191517152326746632